FDA Approves Valbenazine (Ingrezza) for Tardive Dyskinesia FDA Approves Valbenazine (Ingrezza) for Tardive Dyskinesia

The US Food and Drug Administration has approved valbenazine, the first medication for the treatment of tardive dyskinesia.FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news